Global Cell Viability Assays & Consumables Market to 2023 – Increasing Focus on Development of Cell-Based Therapeutics & Potential Biomarkers

NEXT STORY
Intellia Therapeutics Presents New In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeting of the American Society of Gene and Cell Therapy
PREV STORY
Global Viral Vector Manufacturing Market Outlook to 2026 – Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and Recommendations
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19

author_avatar
NASDAQ Market News

United States’ $33.7 Billion IVD Market by Application Segments, Products, Regions, End-users (2013-2025)

author_avatar
NASDAQ Market News

Coherus Announces CHS-1420 Pharmacokinetic Clinical Bioequivalence Study Meets Primary Endpoint

REDWOOD CITY, Calif., March 02, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

author_avatar
NASDAQ Market News